A novel approach to quantify different iron forms in ex-vivo human brain tissue

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Kumar, Pravin ^a   Bulk, Marjolein ^b   Webb, Andrew ^b   Van Der Weerd, Louise ^b   Oosterkamp, Tjerk H ^a   Huber, Martina ^a   Bossoni, Lucia ^a  

^a LEIDEN UNIVERSITY   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC ION; FERRIC OXIDE; IRON; MAGNETITE NANOPARTICLE;

AGED; ALZHEIMER DISEASE; BRAIN CHEMISTRY; CHEMISTRY; ELECTRON SPIN RESONANCE; FEMALE; HUMAN; MAGNETISM; MAGNETOMETRY; METABOLISM; PROCEDURES; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN CHEMISTRY; ELECTRON SPIN RESONANCE SPECTROSCOPY; FEMALE; FERRIC COMPOUNDS; HUMANS; IRON; MAGNETIC PHENOMENA; MAGNETITE NANOPARTICLES; MAGNETOMETRY;

EID: 85006117341     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep38916     Document Type: Article

References (72)

1. Goodman L. Alzheimer?s disease; a clinico-pathologic analysis of twenty-Three cases with a theory on pathogenesis. J. Nerv. Ment. Dis. 118, 97 (1953).
2. Bishop G. M, et al. Iron: A pathological mediator of alzheimer disease? Dev. Neurosci. 24, 184 (2002).
3. Lovell M, Robertson J, Teesdale W, Campbell J, & Markesbery W. Copper, iron and zinc in alzheimer?s disease senile plaques. J. Neurol. Sci. 158, 47-52 (1998).
4. Beard J. L, Connor J. R, & Jones B. C. Iron in the brain. Nutrition Reviews 51, 157-170 (1993).
5. Quintana C, Cowley J, & Marhic C. Electron nanodiffraction and high-resolution electron microscopy studies of the structure and composition of physiological and pathological ferritin. Journal of Structural Biology 147, 166-178 (2004).
6. Quintana C, et al. Study of the localization of iron, ferritin, and hemosiderin in alzheimer?s disease hippocampus by analytical microscopy at the subcellular level. Journal of Structural Biology 153, 42-54 (2006).
7. Pan Y, et al. Electron beam damage studies of synthetic 6-line ferrihydrite and ferritin molecule cores within a human liver biopsy. Micron 37, 403-411 (2006).
8. Kirschvink J. L, Kobayashi-Kirschvink A, & Woodford B. J. Magnetite biomineralization in the human brain. Proc. Natl. Acad. Sci. USA 89, 7683 (1992).
9. Pankhurst Q, Hautot D, Khan N, & Dobson J. Increased levels of magnetic iron compounds in alzheimer?s disease. Journal of Alzheimer?s Disease 13, 49-52 (2008).
10. Brem F, Hirt A. M, Simon C, Wieser H.-G, & Dobson J. Low temperature magnetic analysis in the identification of iron compounds from human brain tumour tissue. Journal of Physics: Conference Series 17, 61 (2005).
11. Ward R. J, Zucca F. A, Duyn J. H, Crichton R. R, & Zecca L. The role of iron in brain ageing and neurodegenerative disorders. The Lancet Neurology 13, 1045-1060 (2014).
12. Núnez M. T, et al. Iron toxicity in neurodegeneration. BioMetals 25, 761-776 (2012).
13. Crichton R. Iron metabolism: from molecular mechanisms to clinical consequences (John Wiley & Sons, 2016).
14. Valko M, Jomova K, Rhodes C. J, Kuča K, & Muslek K. Redox- And non-redox-metal-induced formation of free radicals and their role in human disease. Archives of toxicology 90, 1-37 (2016).
15. Hadzhieva M, Kirches E, & Mawrin C. Review: Iron metabolism and the role of iron in neurodegenerative disorders. Neuropathology and Applied Neurobiology 40, 240-257 (2014).
16. Dobson J. Nanoscale biogenic iron oxides and neurodegenerative disease. FEBS Letters 496, 1-5 (2001).
17. Gossuin Y, et al. Looking for biogenic magnetite in brain ferritin using nmr relaxometry. NMR in biomedicine 18, 469-72 (2005).
18. Michel F. M, et al. The structure of ferrihydrite, a nanocrystalline material. Science 316, 1726-1729 (2007).
19. Gilles C, et al. Magnetic hysteresis and superantiferromagnetism in ferritin nanoparticles. Journal of Magnetism and Magnetic Materials 241, 430-440 (2002).
20. Gossuin Y, Roch A, Muller R. N, Gillis P, & Lo Bue F. Anomalous nuclear magnetic relaxation of aqueous solutions of ferritin: An unprecedented first-order mechanism. Magnetic Resonance in Medicine 48, 959-964 (2002).
21. Everett J, et al
22. Everett J, et al. Evidence of redox-Active iron formation following aggregation of ferrihydrite and the alzheimer?s disease peptide b-Amyloid. Inorganic Chemistry 53, 2803-2809 (2014).
23. Teller S, Tahirbegi I. B, Mir M, Samitier J, & Soriano J. Magnetite-Amyloid-b deteriorates activity and functional organization in an in vitro model for alzheimer?s disease. Scientific Reports 5, 17261 (2015).
24. Langkammer C, Ropele S, Pirpamer L, Fazekas F, & Schmidt R. Mri for iron mapping in alzheimer?s disease. Neurodegenerative Diseases 13, 189-191 (2014).
25. Wood J. C, et al. Mri r2 and r2 mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 106, 1460-1465 (2005).
26. Antharam V, et al. Neuroimage high field magnetic resonance microscopy of the human hippocampus in alzheimer?s disease: Quantitative imaging and correlation with iron
27. Haacke E. M, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magnetic Resonance Imaging 23, 1-25 (2005).
28. Wayne M. W. R, Wieler M, & Gee M. Midbrain iron content in early parkinson disease. Neurology 70, 1411-1417 (2008).
29. House M. J, et al. Correlation of proton transverse relaxation rates (r2) with iron concentrations in postmortem brain tissue from alzheimer?s disease patients. Magnetic Resonance in Medicine 57, 172-180 (2007).
30. House M. J. St, Pierre T. G, & McLean C. 1.4t study of proton magnetic relaxation rates, iron concentrations, and plaque burden in alzheimer?s disease and control postmortem brain tissue. Magnetic Resonance in Medicine 60, 41-52 (2008).
31. Meadowcort M. D, Connor J. R, Smith M. B, & Yang Q. X. Magnetic resonance imaging and histological analysis of beta- Amyloid plaques in both human alzheimer?s disease and app/ps1 transgenic mice. J Magn Reson Imaging 29, 997-1007 (2009).
32. Meadowcroft M. D, Peters D. G, Dewal R. P, Connor J. R, & Yang Q. X. The effect of iron in mri and transverse relaxation of amyloid-beta plaques in alzheimer?s disease. NMR in Biomedicine 28, 297-305 (2015).
33. van Rooden S, et al. Cortical phase changes in alzheimer?s disease at 7t mri: A novel imaging marker. Alzheimer?s & dementia: the journal of the Alzheimer?s Association 10, e19-26 (2014).
34. Nabuurs R. J. A, et al. High-field mri of single histological slices using an inductively coupled, self-resonant microcoil: application to ex vivo samples of patients with alzheimer?s disease. NMR in Biomedicine 24, 351-357 (2011).
35. Meguro R, et al. Nonheme-iron histochemistry for light and electron microscopy: a historical, theoretical and technical review. Archives of histology and cytology 70, 1-19 (2007).
36. Bulk M. Private communication
37. Dobson J, & Grassi P. Magnetic properties of human hippocampal tissue-evaluation of artefact and contamination sources. Brain research bulletin 39, 255-259 (1996).
38. Weir M. P, Peters T. J, & Gibson J. F. Electron spin resonance studies of splenic ferritin and haemosiderin. Biochimica et biophysica acta 828, 298-305 (1985).
39. Alenkina I. V, et al. 57fe mössbauer spectroscopy and electron paramagnetic resonance studies of human liver ferritin, ferrum lek and maltofer (tm). Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy 130, 24-36 (2014).
40. A. Slawska-Waniewskaa A, E. Mosiniewicz-Szablewska E, Nedelko N, Galazka-Friedman J, & Friedman A. Electron paramagnetic resonance studies of human liver tissues. Journal of Magnetism and Magnetic Materials 272-276, 2417-2419 (2004).
41. Cristofolini L, et al. A μ-sr study of the magnetic properties of ferritin. Hyperfine Interactions 104, 269-274 (1997).
42. van Lierop J, Ryan D, Pumarol M, & Roseman M. Muon spin relaxation study of spin dynamics in a polysaccharide iron complex. Journal of Applied Phisics 89, 7645-7647 (2001).
43. Cammack R, & Cooper C. E. Electron paramagnetic resonance spectroscopy of iron complexes and iron-containing proteins. Methods in Enzymology 227, 353 (1993).
44. Bou-Abdallah F, & Chasteen N. D. Spin concentration measurements of high-spin (g = 4.3) rhombic iron(iii) ions in biological samples: theory and application. Journal of Biological Inorganic Chemistry 13, 15-24 (2007).
45. Makhlouf S. A, Parker F. T, & Berkowitz A. E. Magnetic hysteresis anomalies in ferritin. Phys. Rev. B 55, R14717-R14720 (1997).
46. Hautot D, et al. Preliminary observation of elevated levels of nanocrystalline iron oxide in the basal ganglia of neuroferritinopathy patients. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1772, 21-25 (2007).
47. Dar M. I, & Shivashankar S. a. Single crystalline magnetite, maghemite, and hematite nanoparticles with rich coercivity. RSC Advances 4, 4105-4113 (2014).
48. Prozorov R, et al. Magnetic irreversibility and the verwey transition in nanocrystalline bacterial magnetite. Phys. Rev. B 76, 054406 (2007).
49. Özdemir z, Dunlop D. J, & Moskowitz B. M. The effect of oxidation on the verwey transition in magnetite. Geophysical Research Letters 20, 1671-1674 (1993).
50. Cullity B. D, & Graham C. D. Introduction to Magnetic Materials (IEEE Press, 2009).
51. Morales M, s M. A.-V, Veintemillas-Verdaguer S, Montero M, & Serna C. Structural effects on the magnetic properties of ã-fe2o3 nanoparticles. Journal of Magnetism and Magnetic Materials 203, 146-148 (1999).
52. Kim W, et al. A new method for the identification and quantification of magnetite-maghemite mixture using conventional x-ray diffraction technique. Talanta 94, 348-352 (2012).
53. Schäfer-Nolte E, et al. Tracking temperature-dependent relaxation times of ferritin nanomagnets with a wideband quantum spectrometer. Phys. Rev. Lett. 113, 217204 (2014).
54. Zecca L, et al. The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proceedings of the National Academy of Sciences 101, 9843-9848 (2004).
55. Zecca L, et al. Interaction of neuromelanin and iron in substantia nigra and other areas of human brain. Neuroscience 73, 407 (1996).
56. Stadler N, Lindner R. A, & Davies M. J. Direct detection and quantification of transition metal ions in human atherosclerotic plaques: Evidence for the presence of elevated levels of iron and copper. Arteriosclerosis, Thrombosis, and Vascular Biology 24, 949-954 (2004).
57. Kubiak T, Krzyminiewski R, & Dobosz B. Current Topics in Biophysics 36, 7-13 (2013).
58. Patel M, & Ramavataram D. V. S. S. Non transferrin bound iron: Nature, manifestations and analytical approaches for estimation. Indian Journal of Clinical Biochemistry 27, 322-332 (2012).
59. Moser J. C, et al. Pharmacological ascorbate and ionizing radiation (ir) increase labile iron in pancreatic cancer. Redox Biology 2, 22-27 (2014).
60. Pate K. T, Rangel N. a, Fraser B, & Clement M. H. S. NIH Public Access 358, 199-207 (2009).
61. Kell D. B. Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson?s, huntington?s, alzheimer?s, prions, bactericides, chemical toxicology and others as examples. Archives of Toxicology 84, 825-889 (2010).
62. Popescu B. F. G, & Nichol H. Mapping brain metals to evaluate therapies for neurodegenerative disease. CNS neuroscience & therapeutics 17, 256-68 (2011).
63. Brooks R. A, Vymazal J, Goldfarb R. B, Bulte J. W. M, & Aisen P. Relaxometry and Magnetometry of Ferritin. Magnetic Resonance in Medicine 227-235 (1998).
64. Dormann J. L, Fiorani D, & Tronc E. Magnetic relaxation in fine-particle systems. Advances in Chemical Physics XCVIII, 283 (1997).
65. Mercante L, et al. Magnetic properties of nanoscale crystalline maghemite obtained by a new synthetic route. Journal of Magnetism and Magnetic Materials 324, 3029-3033 (2012).
66. Goya G. F, Berquó T. S, Fonseca F. C, & Morales M. P. Static and dynamic magnetic properties of spherical magnetite nanoparticles. Journal of Applied Physics 94, 3520 (2003).
67. Masunaga S. H, Jardim R. F, Fichtner P. F. P, & Rivas J. Role of dipolar interactions in a system of ni nanoparticles studied by magnetic susceptibility measurements. Phys. Rev. B 80, 184428 (2009).
68. Dexter D. T, et al. Alterations in the levels of iron, ferritin and other trace metals in parkinson?s disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114, 1953-1975 (1991).
69. Connor J. R, Snyder B. S, Arosio P, Loeffler D. A, & LeWitt P. A quantitative analysis of isoferritins in selected regions of aged, parkinsonian, and alzheimer?s diseased brains. Journal of Neurochemistry 65, 717-724 (1995).
70. Pardoe H, Chua-Anusorn W, Pierre T. G. S, & Dobson J. Detection limits for ferrimagnetic particle concentrations usingmagnetic resonance imaging based proton transverse relaxation rate measurements. Physics in Medicine and Biology 48, N89 (2003).
71. Hare D. J, et al. The effect of paraformaldehyde fixation and sucrose cryoprotection on metal concentration in murine neurological tissue. Journal of Analytical Atomic Spectrometry 29, 565 (2014).
72. Nabuurs R. J. A, et al. In vivo detection of amyloid-beta deposits using heavy chain antibody fragments in a transgenic mouse model for alzheimer?s disease. PLoS ONE 7, 1-10 (2012).